IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $236,000 | -14.2% | 5,341 | -28.1% | 0.01% | 0.0% |
Q2 2022 | $275,000 | +3337.5% | 7,428 | +4321.4% | 0.01% | – |
Q3 2020 | $8,000 | -90.4% | 168 | -88.1% | 0.00% | -100.0% |
Q2 2020 | $83,000 | +1283.3% | 1,414 | +1209.3% | 0.01% | – |
Q3 2019 | $6,000 | -93.2% | 108 | -90.1% | 0.00% | -100.0% |
Q1 2019 | $88,000 | +319.0% | 1,087 | +175.2% | 0.01% | +400.0% |
Q4 2018 | $21,000 | -97.5% | 395 | -97.6% | 0.00% | -97.9% |
Q3 2018 | $834,000 | +4533.3% | 16,174 | +4521.1% | 0.05% | +4700.0% |
Q4 2017 | $18,000 | -98.9% | 350 | -98.9% | 0.00% | -99.3% |
Q3 2017 | $1,639,000 | +606.5% | 32,329 | +607.4% | 0.15% | +572.7% |
Q2 2017 | $232,000 | +15.4% | 4,570 | -8.7% | 0.02% | +15.8% |
Q1 2017 | $201,000 | +74.8% | 5,004 | +107.3% | 0.02% | +35.7% |
Q4 2016 | $115,000 | +721.4% | 2,414 | +536.9% | 0.01% | +1300.0% |
Q3 2016 | $14,000 | -72.0% | 379 | -82.4% | 0.00% | -85.7% |
Q2 2016 | $50,000 | -60.3% | 2,155 | -30.9% | 0.01% | -61.1% |
Q1 2016 | $126,000 | -79.8% | 3,118 | -69.0% | 0.02% | -81.4% |
Q4 2015 | $624,000 | – | 10,068 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |